An Israeli firm has developed a coronavirus breathalyser test that gives results in 30 seconds, billing it as a “front line” tool that can help restore a sense of normality during the pandemic. “NanoScent”, the firm making the test kits, said an extensive trial in Israel for the presence of live virus delivered results with […]
Israel developed 30-second coronavirus breath test Read More »
DRDO has established a COVID-19 testing facility at the Leh based laboratory Defence Institute of High Altitude Research (DIHAR) to enhance the rate of testing to identify the Corona cases in the Union Territory of Ladakh. The testing facility will also help in keeping close watch of the infected persons. Daily Current Affairs Quiz 2020
DRDO establishes COVID-19 Testing Facility at DIHAR Read More »
All India Institute of Medical Sciences, Nagpur in collaboration with IIT Jodhpur and Indian Institute of Information Technology, Nagpur has indigenously designed and developed a ‘smart wrist band’ for tracking & monitoring of Covid-19 positive and suspect patients. Daily Current Affairs Quiz 2020 Key-Points The wearable tracker’s major objective is to enable remote detection of
AIIMS & IITs develop wrist band to track, monitor covid-19 patients Read More »
The coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response. The widely-followed trial is currently at an advanced stage, with trials in the UK, Brazil and South Africa. Daily Current Affairs Quiz 2020 Key-Points The vaccine – called ChAdOx1 nCoV-19 – is made from a genetically engineered virus that
AIIMS New Delhi has started a video-consultation program with ICU doctors across the country called e-ICU on 8th July, 2020 in order to strengthen the Government of India’s efforts to reduce COVID-19 mortality. Daily Current Affairs Quiz 2020 Key-Points The program aims at holding case-management discussions among doctors who are at the frontline in treating
e-ICU Video Consultation Program of AIIMS Delhi gains traction Read More »
Indian biopharmaceutical company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab (ALZUMAb) for emergency use in Covid-19 patients. Daily Current Affairs Quiz 2020 Key-Points The drug is an anti-CD6 IgG1 monoclonal antibody introduced in India in 2013 under the brand name ALZUMAb to treat chronic
Biocon’s drug Itolizumab gets approval to treat Covid-19 Read More »
The fingerprick tests, which can tell within 20 minutes if a person has ever been exposed to the COVID-19 virus, were found to be 98.6% accurate in secret human trials held in June. British ministers are making plans to distribute millions of free coronavirus antibody tests after a version backed by the UK government passed
COVID-19 antibody test passes first major trials with 98.6% accuracy in UK Read More »
An international study led by a University of Cincinnati College of Medicine researcher suggests that the anxious behaviour or depressed mood in COVID-19 patients may be a sign that the virus affects the central nervous system. These two psychological symptoms were most closely associated with a loss of smell and taste rather than the more
COVID-19 virus may attack the central nervous system of patients Read More »
BIRAC has announced that ZyCoV-D, the plasmid DNA vaccine designed and developed by Zydus and partially funded by the Department of Biotechnology, Government of India has initiated Phase I/ II clinical trials in healthy subjects, making it the first indigenously developed vaccine for COVID-19 to be administered in humans in India. Daily Current Affairs Quiz
Department of Biotechnology supported COVID 19 Vaccine -ZyCoV-D Read More »
Indian pharmaceutical company Zydus has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation. In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated
Zydus begins human trials for potential coronavirus vaccine Read More »
